SGLT2i Benefit Mortality, Cognition in Older CKD Patients

28 Oct 2026 0 comments

Two observational studies have shed light on potentially important effects of SGLT2 inhibitors in older patients who are often underrepresented in clinical trials.
Medscape Medical News

Source: Medscape Neurology Published 28 Oct 2026 Imported 28 Oct 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment